Without insurance, the cost of chemotherapy could be devastating. Out of pocket costs can very quickly fall into the thousands, breaking budgets and depleting savings. When trying to find help, folks are surprised to learn that pharmaceutical companies offer financial assistance with treatment costs. Applying for aid is just a simple as filling out a credit card application, having your doctor verify the info, and submitting the paperwork to the drugmaker. A large number of drugs are covered under the programs and aren’t exclusive to chemotherapy or cancer treatment-related medications.
Eligibility criteria vary among each program. While many programs touch base on low-income individuals, not all programs are income-based. Age could be a mitigating factor for a few applications due to Medicare-related assistance for individuals 65 and over. There are many programs for anyone ineligible for Medicare, as well.
Drug Companies That Help Pay for Cancer Treatments
The first step in getting help for your prescription medications is by determining what drug company makes them. Find out who the drug manufacturer is by simply asking your physician or pharmacist. Check the drug maker’s website because of its prescription discount programs. Your doctor’s office or cancer center could have details about available programs, so make sure you ask them, too.
Below you will see a listing of the larger pharmaceutical companies which have prescription drug assistance programs. Other programs may exist, but these drug makers manufacture nearly all of commonly prescribed medications.
Affording quality healthcare for the typical American is tough enough minus the added challenge of a chronic illness. Arguably, for folks coping with HIV, the problems are more significant given the high cost of HIV drugs, the need for optimal treatment adherence, and the demand for continual, lifelong medical treatment and care.
Consider, for instance, that the average, individual lifetime cost of HIV is well over $400,000—and this for persons who start treatment early and largely prevent the illnesses associated with later-stage (or untreated) disease.
Now add to the expense of HIV therapy, which carries an average price tag of over $2,000 per month, and the obstacles grow even brighter. Even with prescription drug coverage, several medications remain unaffordable because of “adverse tiering” practices by which insurers can demand anywhere from 20 percent to 50 percent coinsurance payment for every and every drug prescription.
This means that a person with a “low” 20 percent coinsurance benefit could easily pay between $440 to $480 per month to get Triumeq, a normally standard, one-pill option. And that doesn’t even take into consideration the expense of deductibles and other out-of-pocket expenses that could total up to 1000s of dollars before your benefits even kick in.
However daunting the prospects may be—particularly for middle-income earners who can afford neither co-payments nor access benefits provided lower-income groups—you will find remedies. Some may need you to adjust your overall insurance strategy, while others may allow you access to assistance programs that you might have otherwise thought yourself unqualified.